GZUHY yields 217.39% · JNJ yields 2.13%● Live data
📍 GZUHY pulled ahead of the other in Year 1
Combined, GZUHY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GZUHY + JNJ for your $10,000?
Guangzhou R&F Properties Co., Ltd., together with its subsidiaries, engages in the development and sale of residential and commercial properties in the People's Republic of China, Malaysia, Cambodia, Korea, the United Kingdom, and Australia. The company invests in and develops various properties, including hotels, office buildings, shopping malls, logistics parks, and other retail properties in Beijing, Guangzhou, and other cities; and engages in construction business. It is also involved in the operation and management of hotels and a theme park under the Hainan R&F Ocean Paradise name; provides property management and leasing, and architectural and engineering design services, as well as marketing development services; and operates a football club. In addition, the company operates offline exhibition and trading complex; and offers online ecological industry operation platform services. Further, it operates diet, healthcare, sports, and culture and entertainment centers; and a hospital that provides prevention and healthcare, health assessment and management, diagnosis, treatment, and rehabilitation services, as well as elderly care services. Additionally, the company provides planning and designing, supervision, construction, landscaping, electrical and service installation, and interior decoration services. It also engages in the design and consulting of buildings and urban planning projects; installation of electromechanical and crane equipment, fire-fighting facilities, intelligent construction, power supply, and distribution projects. As of December 31, 2021, the company operated 93 deluxe hotels. Guangzhou R&F Properties Co., Ltd. was founded in 1994 and is headquartered in Guangzhou, the People's Republic of China.
Full GZUHY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.